iZafe Group

iZafe Group ROCE

The Return on Capital Employed (ROCE) of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is -157.38 %. In the previous year, Return on Capital Employed (ROCE) was -199.68 % — a change of -21.18% (higher).

ROCE

-157.38 %

YoY

-21.18%

Last updated:

In 2025, iZafe Group's return on capital employed (ROCE) was -157.38 %, a -21.18% increase from the -199.68 % ROCE in the previous year.

The iZafe Group ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
-106.15 SEK
Jan 1, 2019
-61.24 SEK
Jan 1, 2020
-41.12 SEK
Jan 1, 2021
-81.69 SEK
Jan 1, 2022
-60.07 SEK
Jan 1, 2023
-139.93 SEK
Jan 1, 2024
-199.68 SEK
Jan 1, 2025
-157.38 SEK
The iZafe Group ROCE history
YEARROCEYoY
-157.38 %-21.18%
-199.68 %+42.70%
-139.93 %+132.94%
-60.07 %-26.46%
-81.69 %+98.67%
-41.12 %-32.86%
-61.24 %-42.31%
-106.15 %+180.20%
-37.88 %-68.27%
-119.41 %+255.82%
-33.56 %-13.57%
-38.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling iZafe Group's Return on Capital Employed (ROCE)

iZafe Group's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing iZafe Group's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

iZafe Group's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in iZafe Group’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about iZafe Group stock

Return on Capital Employed (ROCE) of iZafe Group is -157.38 % in 2025.

Return on Capital Employed (ROCE) of iZafe Group changed from -199.68 % to -157.38 %, representing a -21.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) iZafe Group since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s iZafe Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — iZafe Group

All Key Metrics — iZafe Group